Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 study of forodesine in Japanese recurrent/refractory peripheral T-cell lymphoma
jRCT2080221940Phase 2
- Sponsor
- Mundipharma
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of forodesine in peripheral T-cell lymphoma (PTCL), sponsored by Mundipharma.
02
Drugs
forodesine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on jRCT2080221940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221940.